Macrocyclic Supramolecular Assemblies Based on Hyaluronic Acid and Their Biological Applications
Макроциклические супрамолекулярные сборки на основе гиалуроновой кислоты и их биологические применения
2022-11-16
SCID: 54.1/zqeghr6f
Discuss with AI
biological applicationshyaluronic acidmacrocyclic host–guest complexesstimuli-responsive drug deliverysupramolecular drug carriers
Figures from the paper
Abstract (AI)
Conspectus Hyaluronic acid (HA), which contains multiple carboxyl, hydroxyl, and acetylamino groups and is an agent that targets tumors, has drawn great attention in supramolecular diagnosis and treatment research. It can not only assemble directly with macrocyclic host–guest complexes through hydrogen bonding and electrostatic interactions but also can be modified with macrocyclic compounds or functional guest molecules by an amidation reaction and used for further assembly. Macrocycles play a main role in the construction of supramolecular drug carriers, targeted imaging agents, and hydrogels, such as cyclodextrins and cucurbit[ n ]urils, which can encapsulate photosensitizers, drugs, or other functional guest molecules via host–guest interactions. Therefore, the formed supramolecular assemblies can respond to various stimuli, such as enzymes, light, electricity, and magnetism for controlled drug delivery, enhance the luminescence intensity of the assembly, and improve drug loading capacity. In addition, the nanosupramolecular assembly formed with HA can also improve the biocompatibility of drugs, reduce drug toxicity and side effects, and enhance cell permeability; thus, the assembly has extensive application value in biomedical research. This Account mainly focuses on macrocyclic supramolecular assemblies based on HA, especially their biological applications and progress in the field, and these assemblies include (i) guest-modified HA, such as pyridinium-, adamantane-, peptide-, and other functional-group-modified HA, along with their cyclodextrin and cucurbit[ n ]uril assemblies; (ii) macrocycle-modified HA, such as HA modified with cyclodextrins and cucurbit[ n ]uril derivatives and their assembly with various guests; (iii) direct assembly between unmodified HA and cyclodextrin- or cucurbit[n]uril-based host–guest complexes. Particularly, we discussed the important role of macrocyclic host–guest complexes in HA-based supramolecular assembly, and the roles included improving the water solubility and efficacy of hydrophobic drugs, enhancing the luminescent intensity of assemblies, inducing room temperature phosphorescence and providing energy transfer systems, constructing multi-stimulus-responsive supramolecular assemblies, and in situ formation of hydrogels. Additionally, we believe that obtaining in-depth knowledge of these HA-based macrocyclic supramolecular assemblies and their biological applications encompasses many challenges regarding drug carriers, targeted imaging agents, wound healing, and biomedical soft materials and would certainly contribute to the rapid development of supramolecular diagnosis and treatment.
Key Findings
1
Amidation enables HA modification with macrocycles or functional guest molecules, expanding the structures available for supramolecular assembly.
2
Cyclodextrin- and cucurbit[n]uril-based assemblies can encapsulate photosensitizers, drugs, and other functional guests for drug delivery, imaging, and hydrogel applications.
3
HA-based macrocyclic assemblies can respond to enzymes, light, electricity, and magnetism, enabling stimulus-controlled drug delivery and enhanced luminescence or drug loading.
4
Hyaluronic acid can directly assemble with macrocyclic host–guest complexes through hydrogen bonding and electrostatic interactions.
5
Nanosupramolecular assemblies with HA can improve biocompatibility and cell permeability while reducing drug toxicity and side effects.
Research Object
Macrocyclic supramolecular assemblies based on hyaluronic acid (HA)
Research Subject
Their biological applications and assembly-related properties, including stimulus-responsive controlled drug delivery, imaging, drug loading, biocompatibility, toxicity, and cell permeability
Publication Details
Publication Date
2022-11-16
Journal
Publisher
ISSN
Cited by
122
Access Type
Author Information
Download PDF
Subscribe to digest